Pee Cee Cosma Sope Fair Value
Pee Cee Cosma Sope (PCCOSMA) average fair value is ₹253.5 across 6 valuation models — P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹303.05 (-16.35%), fair value range ₹75.1–₹457.33. For live price and a broader fundamental view, visit PCCOSMA stock price BSE.
Fair Value Analysis Export
PCCOSMA Fair Value vs Current Price — Valuation Summary
PCCOSMA average fair value, fair value range, price gap and valuation status across 6 models: P/E Based Valuation, P/B Based Valuation, Price-to-Sales Valuation, Asset-Based Valuation, Benjamin Graham Number, Discounted Cash Flow (DCF). Check Pee Cee Cosma Sope market worth to track the company's total market size over time.
P/E Based Valuation
P/B Based Valuation
Price-to-Sales Valuation
Asset-Based Valuation
Benjamin Graham Number
Discounted Cash Flow (DCF)
PCCOSMA Fair Value Analysis — Data Sources & Coverage
Pee Cee Cosma Sope financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
PCCOSMA vs Consumer Goods Sector Peers — P/E, P/B & Market Cap
Pee Cee Cosma Sope P/E ratio, P/B ratio and market capitalisation vs Consumer Goods sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| IFB Industries | IFBIND | 36.76 | 5.31 | ₹5,284 |
| Bata | BATAINDIA | 64.85 | 5.45 | ₹8,868 |
| Eureka Forbes | EUREKAFORB | 54.9 | 1.94 | ₹8,973 |
| Lamosaic India | LAMOSAIC | - | - | ₹46 |
| Berger Paints | BERGEPAINT | 51.49 | 8.39 | ₹57,566 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.